Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariel Berger

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Clinical Therapeutics|February 26, 2025
Impact of Vagus Nerve Stimulation for the Treatment of Drug-resistant Epilepsy on Patterns of Use and Cost of Healthcare Services and Pharmacotherapy Among Medicare Enrollees: Findings From Analyses of Healthcare Claims From the Centers of Medicare and Medicaid ServicesKathryn Evans, Qian Li, Yuliya Halchenko, et al.
Epilepsy & Behavior : E&B|June 22, 2023
Patterns of utilization and cost of healthcare services and pharmacotherapy among patients with drug-resistant epilepsy during the two-year period before neurostimulation: A descriptive analysis of the journey to implantation based on analyses of a large United States healthcare claims databaseKathryn Evans, Nicole Stamas, Qian Li, et al.
Antibiotics (Basel, Switzerland)|December 23, 2022
Epidemiology and Economic Outcomes Associated with Timely versus Delayed Receipt of Appropriate Antibiotic Therapy among US Patients Hospitalized for Native Septic Arthritis: A Retrospective Cohort StudyJoan-Miquel Balada-Llasat, Nicole Stamas, Tom Vincent, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|February 6, 2014
Can dialysis patients be accurately identified using healthcare claims data?Charu Taneja, Ariel Berger, Gary W Inglese, et al.
Journal of Medical Economics|November 17, 2022
Comparison of utilization and cost of healthcare services and pharmacotherapy following implantation of vagus nerve stimulation <i>vs.</i> responsive neurostimulation or deep brain stimulation for the treatment of drug-resistant epilepsy: analyses of a large United States healthcare claims databaseTom Vincent, Qian Li, Lu Zhang, et al.
The American Journal of Cardiology|April 25, 2019
Incidence and Cost of Major Adverse Cardiovascular Events and Major Adverse Limb Events in Patients With Chronic Coronary Artery Disease or Peripheral Artery DiseaseAriel Berger, Alex Simpson, Tarun Bhagnani, et al.
Future Oncology (London, England)|January 17, 2024
Development and validation of algorithms for identifying lines of therapy in multiple myeloma using real-world dataSikander Ailawadhi, Dorothy Romanus, Surbhi Shah, et al.
The Journal of Spinal Cord Medicine|October 15, 2020
Incidence of urinary tract infection following initiation of intermittent catheterization among patients with recent spinal cord injury in Germany and the NetherlandsAriel Berger, Jimena Goldstine, Cheriel Hofstad, et al.
The Western Journal of Emergency Medicine|July 18, 2018
Emergency Department Time Course for Mild Traumatic Brain Injury WorkupEdward A Michelson, J Stephen Huff, Mae Loparo, et al.
Clinical Therapeutics|February 6, 2023
Impact of Vagus Nerve Stimulation for the Treatment of Drug-resistant Epilepsy on Patterns of Use and Cost of Health Care Services and Pharmacotherapy: Comparisons of the 24-Month Periods Before and After ImplantationKathryn Evans, Nicole Stamas, Qian Li, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Clinical Therapeutics|February 26, 2025
Impact of Vagus Nerve Stimulation for the Treatment of Drug-resistant Epilepsy on Patterns of Use and Cost of Healthcare Services and Pharmacotherapy Among Medicare Enrollees: Findings From Analyses of Healthcare Claims From the Centers of Medicare and Medicaid ServicesKathryn Evans, Qian Li, Yuliya Halchenko, et al.
Epilepsy & Behavior : E&B|June 22, 2023
Patterns of utilization and cost of healthcare services and pharmacotherapy among patients with drug-resistant epilepsy during the two-year period before neurostimulation: A descriptive analysis of the journey to implantation based on analyses of a large United States healthcare claims databaseKathryn Evans, Nicole Stamas, Qian Li, et al.
Antibiotics (Basel, Switzerland)|December 23, 2022
Epidemiology and Economic Outcomes Associated with Timely versus Delayed Receipt of Appropriate Antibiotic Therapy among US Patients Hospitalized for Native Septic Arthritis: A Retrospective Cohort StudyJoan-Miquel Balada-Llasat, Nicole Stamas, Tom Vincent, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|February 6, 2014
Can dialysis patients be accurately identified using healthcare claims data?Charu Taneja, Ariel Berger, Gary W Inglese, et al.
Journal of Medical Economics|November 17, 2022
Comparison of utilization and cost of healthcare services and pharmacotherapy following implantation of vagus nerve stimulation <i>vs.</i> responsive neurostimulation or deep brain stimulation for the treatment of drug-resistant epilepsy: analyses of a large United States healthcare claims databaseTom Vincent, Qian Li, Lu Zhang, et al.
The American Journal of Cardiology|April 25, 2019
Incidence and Cost of Major Adverse Cardiovascular Events and Major Adverse Limb Events in Patients With Chronic Coronary Artery Disease or Peripheral Artery DiseaseAriel Berger, Alex Simpson, Tarun Bhagnani, et al.
Future Oncology (London, England)|January 17, 2024
Development and validation of algorithms for identifying lines of therapy in multiple myeloma using real-world dataSikander Ailawadhi, Dorothy Romanus, Surbhi Shah, et al.
The Journal of Spinal Cord Medicine|October 15, 2020
Incidence of urinary tract infection following initiation of intermittent catheterization among patients with recent spinal cord injury in Germany and the NetherlandsAriel Berger, Jimena Goldstine, Cheriel Hofstad, et al.
The Western Journal of Emergency Medicine|July 18, 2018
Emergency Department Time Course for Mild Traumatic Brain Injury WorkupEdward A Michelson, J Stephen Huff, Mae Loparo, et al.
Clinical Therapeutics|February 6, 2023
Impact of Vagus Nerve Stimulation for the Treatment of Drug-resistant Epilepsy on Patterns of Use and Cost of Health Care Services and Pharmacotherapy: Comparisons of the 24-Month Periods Before and After ImplantationKathryn Evans, Nicole Stamas, Qian Li, et al.
Pageof 7